Reducing racial and ethnic disparities in cardiovascular outcomes among cancer survivors
Min Choon Tan(Saint Michael's Medical Center), Avirup Guha(The Ohio State University Wexner Medical Center), Nickolas Stabellini(University Hospitals Seidman Cancer Center), Jia Yean Thong(Shanghai Medical College of Fudan University), Vanessa B. Sheppard(Virginia Commonwealth University), Catherine C. Hedrick(La Jolla Institute for Immunology), Justin X. Moore(Augusta University), Arnethea L. Sutton(Virginia Commonwealth University), Jia Yi Tan(APLA Health), Jennifer Cullen(Case Western Reserve University), Neeraj Agarwal(Huntsman (United States)), Anika L Hines(Virginia Commonwealth University)
Cited by 1
Related Papers
TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors
|Journal of Clinical Oncology|2021|530
Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis
|Nature Communications|2018|179
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
|Nature Reviews Clinical Oncology|2021|140
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
|Cancer Discovery|2024|137